Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

Biotechnology

Health Care

Life Sciences

Therapeutics

Crossbow Therapeutics, Inc

Briggs Morrison

Vinutha Chandrababu

Tao Wang

Bhupal Ban

Benjamin Lee

Amanda Mak

Dmitri Wiederschain

The Leadership Team at Crossbow Therapeutics, Inc. is responsible for steering the strategic vision and operations of the company. Comprised of key executives such as the CEO, Chief Scientific Officer, and Senior Vice Presidents, this team ensures the effective development and deployment of the company’s cutting-edge T-Bolt™ therapies, manages high-level research and product discovery, and oversees the translation of scientific breakthroughs into actionable cancer treatments.

Leadership Team

Scientific Research and Development

Leadership Team

About

Team members

Other teams at Crossbow Therapeutics, Inc

Scientific Research and Development